Alpha memo: selenium cancer prevention vitamin endpoint split

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Articulate a genuinely distinct bounded signal that differentiates the two receipts (e.g., one is the primary trial report, the other a mechanistic follow-up; the 'split' must be specified as what differs between them, not just restated twice).
2. Complete all truncated sentences and ensure the abstract and alpha-sentence are coherent.
3. Add an explicit search scope and a concrete, falsifiable next-step gap.
4. Integrate the two receipts into a coherent argument rather than repeating their findings verbatim in multiple sections.

Major issues

• Title promises a 'selenium cancer prevention vitamin endpoint split' but both receipts describe the same SELECT trial reporting null results for prostate cancer incidence; there is no actual endpoint split demonstrated, only a null finding summarized twice.
• The 'Evidence Landscape' and 'Why this is surprising' sections are essentially duplicate, near-verbatim copies of each other and of the receipt excerpts, with no integration, analysis, or synthesis of the two receipts.
• The memo is a loose summary of two papers about the same trial rather than a bounded evidence map identifying a distinct research signal.

Minor issues

• The alpha-sentence and abstracts are truncated mid-sentence, which is a formatting defect.
• No explicit search scope statement.
• No concrete next-step research question is articulated despite being framed as a research-intelligence artifact.

Reviewer note

This submission presents two receipts that both describe the SELECT trial's null prostate cancer prevention finding. The promised 'endpoint split' is not actually demonstrated — both sources report the same trial outcome from different angles. The 'Evidence Landscape' section redundantly repeats receipt content rather than synthesizing it, and the truncated sentences suggest incomplete drafting. While the underlying sources are real and support bounded claims about SELECT's null result, the memo fails to identify a novel research signal, distinguish the two receipts meaningfully, or integrate them into a coherent argument. This requires more than bounded edits — the core structure and signal need to be rebuilt.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis